USP logo
Patient Teaching Aid

Glucagon-Like Peptide-1 Receptor Agonists

A variety of glucagon-like peptide-1 receptor agonists are available, but not all of them are approved for type 2 diabetes and weight management.

USP logo
USP logo

LATEST FEATURES

Resmetirom for Metabolic Dysfunction–Associated Steatohepatitis
In 2024, resmetirom became the first FDA-approved treatment for adults who have noncirrhotic metabolic dysfunction–associated steatohepatitis with moderate-to-advanced fibrosis.
Trends in Older Adults’ Vaccine Uptake
Reduced vaccination rates in older adults are especially concerning since this population is at increased risk for morbidity and mortality.

LATEST NEWS

CONTINUING EDUCATION
AUG 13, 2025 . 2 CREDITS
Pharmacist Involvement in HPV Vaccination for Cancer Prevention
JUN 30, 2025 . 2 CREDITS
A Review of the Prevention and Treatment of Influenza
MAY 31, 2025 . 2 CREDITS
Management of Male Urinary Incontinence
APR 30, 2025 . 2 CREDITS
Improving Clinical Outcomes for Generalized Anxiety Disorder

Latest Issues

March 2026
MARCH 2026

TOPIC

February 2026
FEBRUARY 2026

CARDIOVASCULAR DISEASE

January 2026
JANUARY 2026

GASTROENTEROLOGY

December 2025
DECEMBER 2025

TOPIC

November 2025
NOVEMBER 2025

TOPIC

LATEST DEPARTMENTS

Human papillomavirus is not curable, but the immune system is typically able to dispel it spontaneously, usually within 2 years.

Reduced vaccination rates in older adults are especially concerning since this population is at increased risk for morbidity and mortality.
For effective treatment, the pharmacologic approach should be targeted to the specific
type of pain the patient is experiencing, whether nociceptive or neuropathic.

Emily M. Ambizas, PharmD, MPH, BCGP
Associate Clinical Professor
St. John’s University, College of Pharmacy & Health Sciences
Queens, New York
Clinical Specialist, Walgreens Pharmacy
Oakdale, New York

A multidisciplinary approach to treatment is necessary, as the multifactorial causes of this complex condition must be managed to achieve optimal care.

Manouchehr Saljoughian, PharmD, PhD

PHARMACIST QUIZ